AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh

Posted on July 22, 2025 by

AstraZeneca said the “cornerstone” of the commitment would be a new weight management production facility for its oral GLP-1 drug.

U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote